Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Advanced Human Imaging Limited Sponsored ADR (AHI : NSDQ)
 
 • Company Description   
Advanced Human Imaging developed and patented a proprietary dimensioning technology which enables its users to check, track and assess their dimensions in conjunction with known health risk indicators using only a smartphone both privately and accurately. Advanced Human Imaging is based in PERTH, Australia.

Number of Employees: 19

 
 • Price / Volume Information   
Yesterday's Closing Price: $0.37 Daily Weekly Monthly
20 Day Moving Average: 23,430 shares
Shares Outstanding: 28.01 (millions)
Market Capitalization: $10.49 (millions)
Beta: 1.86
52 Week High: $1.80
52 Week Low: $0.35
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -21.94% -19.42%
12 Week -2.73% -5.35%
Year To Date -8.61% -11.20%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
Unit 5 71-73 The Esplanade
-
South Perth,C3 6151
AUS
ph: 61-8-9324-2099
fax: -
hello@ahi.tech http://www.ahi.tech
 
 • General Corporate Information   
Officers
Vlado Bosanac - Chief Executive Officer and Chairman
Steven Richards - Chief Financial Officer
Mike Melby - Director
Dato Low Koon Poh - Director
Edward Greissing Jr - Director

Peer Information
Advanced Human Imaging Limited Sponsored ADR (EVOL)
Advanced Human Imaging Limited Sponsored ADR (RAMP)
Advanced Human Imaging Limited Sponsored ADR (ALOT)
Advanced Human Imaging Limited Sponsored ADR (TGHI)
Advanced Human Imaging Limited Sponsored ADR (GNCMA)
Advanced Human Imaging Limited Sponsored ADR (GSIC)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: Technology Services
Sector: Business Services
CUSIP: 00777C104
SIC: 7372
Fiscal Year
Fiscal Year End: June
Last Reported Quarter: -
Next Expected EPS Date: -
Share - Related Items
Shares Outstanding: 28.01
Most Recent Split Date: (:1)
Beta: 1.86
Market Capitalization: $10.49 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: -  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 2.52
Price/Cash Flow: -
Price / Sales: -
EPS Growth
vs. Year Ago Period: -%
vs. Previous Quarter: -%
Sales Growth
vs. Year Ago Period: -%
vs. Previous Quarter: -%
ROE
12/31/22 - -
09/30/22 - -
06/30/22 - -
ROA
12/31/22 - -
09/30/22 - -
06/30/22 - -
Current Ratio
12/31/22 - 0.90
09/30/22 - -
06/30/22 - 3.40
Quick Ratio
12/31/22 - -
09/30/22 - -
06/30/22 - 3.40
Operating Margin
12/31/22 - -
09/30/22 - -
06/30/22 - -
Net Margin
12/31/22 - -
09/30/22 - -
06/30/22 - -
Pre-Tax Margin
12/31/22 - -
09/30/22 - -
06/30/22 - -4,724.22
Book Value
12/31/22 - 0.15
09/30/22 - -
06/30/22 - 0.26
Inventory Turnover
12/31/22 - -
09/30/22 - -
06/30/22 - -
Debt-to-Equity
12/31/22 - 0.05
09/30/22 - -
06/30/22 - 0.00
Debt-to-Capital
12/31/22 - 5.17
09/30/22 - -
06/30/22 - 0.00
 

Powered by Zacks Investment Research ©